[ad_1]
The experimental drug Remdesivir can be administered to greedy patients in healthcare in the United States as early as next week. In any case, according to Gilead, the company behind the drug.
Remdesivir has been previously developed for the treatment of Ebola, but in that case it did not show any desired effect. Stock Photography.
– We plan to give it to patients early next week and start working with the government, which will decide which cities are most at risk and where are the patients who need this drug, CEO Daniel O’Day says in the television. “Face the nation” of the CBC company.
Gilead has donated his entire stockpile of medications to the US government. UU., Says the CEO of the television channel.
On Friday, the US FDA. USA Decided that Remdesivir can be used in US health care. USA During the current emergency, even though it has not been formally approved as a drug. The decision came after the US Health Authority. USA NIH will demonstrate that the experimental drug is effective in the treatment of covid-19.
Already on Wednesday, Gilead showed promising but preliminary results from his own study. The encouraging news caused the company’s shares to rush to the stock market and also boosted the other trade on Wall Street.
But the effect of the drug is controversial. A Chinese study shows that Remdesivir does not accelerate the recovery of seriously ill greedy patients.
The EU is now investigating whether the drug should be approved for use. The Swedish Medicines Agency collaborates with the German authorities to analyze the results of the American study. On Saturday, the Swedish Medicines Agency told TV4 News that it may be days before that decision is made. On Sunday, the authority informs TT that it is unclear if a message can arrive next week, but that the matter is of high priority.
